On June 13, 2026 Principal, Ms. Pauli Wongspoke at the “Entrepreneurial Workshop,” an elective course under the Master of Technology Entrepreneurship program at the Hong Kong Polytechnic University (PolyU).

Invited as the course's external expert, Pauli shared her extensive expertise with an audience of approximately 35 aspiring tech entrepreneurs, primarily from mainland China.

The interactive session focused on the highly relevant topic “如何运用专利构建科技企业的护城河” (How to Use Patents to Build a Moat for Tech Enterprises).” Drawing from her deep background in patent drafting and global prosecution, Pauli provided real-world case studies, strategic advice, and practical insights on how startups can effectively leverage intellectual property as a defensive moat to protect their tech innovations and scale their businesses safely.

Our Past Events

Recommended Insights

IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law: Part 1: Delayed Examination

25 January 2024
December 2023 appears to have been an exceptionally busy and fruitful month in the China patent space. Following the State Council’s approval of the long-awaited Patent Law Implementation Regulations (“Regulations”, similar to the CFR in the US) in November, the CNIPA finally made public the full text of the Regulations just before the arrival of […]

Inventive Step for an Enantiomer over a Racemate: “L-ornidazole” Patent Invalidation Case

27 November 2023
Each year, China’s Supreme People’s Court (SPC) issues its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in the previous year. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]

Is “Comparable” the New “Unexpected”? China’s SPC Relaxes Inventive Step Standard for Breakthrough Therapeutics

14 July 2026
How the Supreme People's Court Established a New Benchmark for Unexpected Technical Effects in a Landmark Diabetic Nephropathy Case Proving inventive step for pharmaceutical compounds, especially a second medical use, remains one of the most challenging aspects of patent prosecution in China. When the prior art discloses a compound's general therapeutic properties, how can an […]

Breaking News: China passes Fourth Amendment to the Chinese Patent Law

19 October 2020
After 12 years, the Fourth Amendment to the Chinese Patent Law has passed and will be in effect on 1 Jun 2021. After years of multiple draft amendments that moved in various directions, we FINALLY have some clarity on what patent protection is going to look like in China in the coming future. Many of […]
Top crossarrow-right